Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Argus Health
Deloitte
Harvard Business School
Baxter
US Department of Justice
McKesson
Merck
Medtronic

Generated: August 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084423

« Back to Dashboard

NDA 084423 describes PROMAPAR, which is a drug marketed by Parke Davis and is included in five NDAs. Additional details are available on the PROMAPAR profile page.

The generic ingredient in PROMAPAR is chlorpromazine hydrochloride. There are twenty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.
Summary for 084423
Tradename:PROMAPAR
Applicant:Parke Davis
Ingredient:chlorpromazine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Deloitte
Teva
Johnson and Johnson
Argus Health
Healthtrust
Chinese Patent Office
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.